Our company exists since 1991 and is a Polish producer and distributor of innovative aerosol therapy equipment.
Our products are available throughout the country through intermediaries and an online store. Our range includes a wide range of inhalers and inhalation accessories.
We provide comprehensive equipment for inhalation of hospitals, sanatoriums, rehabilitation centers and private therapeutic rooms.
We run a service that provides all our customers with fast and efficient service throughout the country. We offer training and workshops in the selection and use of inhalation equipment.
We also design and perform functional inhalation stations that effectively clean treatment rooms from unnecessary aerosol, reducing equipment wear.
As part of a comprehensive offer for many years, we represent the Italian company Flaem Nuova - a manufacturer of high quality inhalers such as the popular Elisir; a French DTF company - a manufacturer of a unique otolaryngological inhaler for the treatment of middle ear disorders and other valued companies dealing with the topic of inhalation.
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
33.13.Z - Repair and maintenance of electronic and optical equipment
46.46.Z - Wholesale of pharmaceutical goods
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.29.Z - Rental and leasing of other personal and household goods
96.09.Z - Other personal service activities not elsewhere classified
2018 | 2019 | 2020 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | -0,1 | 0 | 143,8 |
Gross profit (loss) | 0 | -0,1 | 0,1 | 214,1 |
EBITDA | 0 | -0,1 | 0,1 | 234,1 |
Short time liabilities | 0,1 | 0,1 | 0,1 | -32,3 |
Other operating costs | 0 | 0 | 0,1 | 3886,2 |
Equity capital | 0,4 | 0,4 | 0,4 | 21,7 |
Operating profit (EBIT) | 0 | -0,1 | 0,1 | 219,3 |
Assets | 0,7 | 0,5 | 0,8 | 51,3 |
Net profit (loss) | 0 | -0,1 | 0,1 | 207,4 |
Cash | 0,1 | 0 | 0,1 | 274,5 |
Net income from sale | 1,5 | 1,3 | 1,4 | 11 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,4 | 113,7 |
Working assets | 0,6 | 0,5 | 0,8 | 50,8 |
Other income costs | 0 | 0 | 0,1 | 903,4 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 3,2 | -18,6 | 16,4 | 35 |
Equity capital to total assets | 63,6 | 67,9 | 54,6 | -13,3 |
Gross profit margin | 0,9 | -5,1 | 5,2 | 10,3 |
EBITDA Margin | 1,5 | -4,4 | 5,4 | 9,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 32 | 39 | 24 | -15 |
Current financial liquidity indicator | 4.834476470947266 | 3.755100965499878 | 8.362264633178711 | 4,6 |
Net dept to EBITDA | -3.637159585952759 | 0.6266595125198364 | -1.7506656646728516 | -2,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane